Consolidated financial statement of the Eurosystem as at 21 June 2019

In the week ending 21 June 2019 gold and gold receivables (asset item 1) remained unchanged. The net position of the Eurosystem in foreign currency (asset items 2 and 3 minus liability items 7, 8 and 9) decreased by EUR 0.1 billion to EUR 288.5 billion. As a result of the Eurosystem’s open market operations and standing facilities, net lending to credit institutions (asset item 5 […]

Management Board supports efforts to improve REACH authorisation and evaluation

ECHA’s Management Board has expressed its confidence in the plans to adjust the process for applications for authorisation. The Board also welcomed the joint action plan of ECHA and the European Commission to improve the compliance of REACH registrations. Helsinki, 20 June 2019 – “ECHA is investing a lot to improve these two critical processes for the […]

European Environment Agency marks its 25th anniversary by reflecting on future challenges at high-level seminar

The European Environment Agency (EEA) is marking its 25th anniversary today with a special meeting involving senior officials and experts from the EEA’s 39 member and cooperating countries, the European Commission, and the European Parliament. The participants will contribute to a new, 10-year strategy to steer the future work of the Agency and its network […]

Climate change puts pressure on Europe’s energy system

All parts of Europe’s energy system, from availability of energy sources to energy consumption, are potentially vulnerable to climate change and extreme weather events, according to a European Environment Agency report, published today. To secure reliable supply of clean energy, Europe’s energy system needs to adapt and become more climate resilient, the report states.

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 11-14 June 2019

PRAC starts review of leuprorelin medicines EMA’s safety committee (PRAC) has started a review of leuprorelin medicines after reports indicated that handling errors during preparation and administration can cause some patients to receive insufficient amounts of their medicine, thus reducing the benefits of treatment.